---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-100443"
form_type: "8-K"
ticker: "PFSA"
cik: "0001859807"
company_name: "Profusa, Inc."
filed_at: "2025-10-21T23:59:59+00:00"
generated_at: "2026-05-17T03:04:45.109998+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Profusa publishes updated investor presentation; no material specifics in filing excerpt

## Summary
- Updated investor presentation posted on company website on October 20, 2025.
- Presentation includes forward-looking statements and risk factors.
- No financial results, guidance, or material business updates disclosed in available excerpt.
- Company tagline: 'Pioneering real time biochemistry that drives AI-led, personalized healthcare technologies.'

## SEC filing metadata
- accession: 0001213900-25-100443
- form_type: 8-K
- ticker: PFSA
- cik: 0001859807
- company_name: Profusa, Inc.
- filed_at: 2025-10-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859807/000121390025100443/0001213900-25-100443-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859807/000121390025100443/ea0261836-8k_profusa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-100443
- JSON: https://secwatch.observer/filing/0001213900-25-100443.json
- Plain text: https://secwatch.observer/filing/0001213900-25-100443.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.